ThermoGenesis Holdings, Inc. — formerly known as Cesca Therapeutics, Inc. — is a California-based pioneer and market leader in the development and commercialization of automated cell processing technologies for the cell and gene therapy fields.. ThermoGenesis manufactures batches, as well as cGMP material for clinical trials. They work in modalities including T cells, T cell receptor, tumor-infiltrating leukocytes, NK cells, iPSCs, and mesenchymal stem cells.